Literature DB >> 29927374

Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan.

Mitsuyo Kawaguchiya1, Noriko Urushibara1, Meiji Soe Aung1, Shigeo Morimoto2, Masahiko Ito2, Kenji Kudo2, Nobumichi Kobayashi1.   

Abstract

PURPOSE: Among the pneumococcal proteins, pneumococcal surface protein A (PspA) is considered the most promising candidate for a serotype-independent vaccine. This study aimed to investigate the serotype, genetic diversity of PspA, lineage (genotype) and drug resistance traits of pneumococcal isolates from paediatric patients.
METHODOLOGY: A total of 678 non-invasive pneumococcal isolates obtained from June to November 2016 were analysed. All isolates were characterized for PspA families, serotypes and macrolide resistance genes. Seventy-one representative isolates of non-vaccine serotypes (NVTs) were genetically analysed for the clade-defining region (CDR) of PspA, as well as multi-locus sequence typing (MLST).
RESULTS: The detection rate of NVTs was 87.9 % (n=596), including dominant NVTs 15A (14.5 %, n=98), 35B (11.8 %, n=80), 15C (9.3 %, n=63) and 23A (9.0 %, n=61). Most isolates (96.6 %) possessed macrolide resistance genes erm(B) and/or mef(A/E). PspA families 1, 2 and 3 were detected in 42.3, 56.6 and 0.6 % of isolates, respectively. Nucleotide sequences of CDR showed high identity (90-100 %) within the same PspA clade, although the CDR identity among different PspA families ranged from 53 to 69 %. All isolates of NVTs 23A, 10A, 34, 24, 22F/22A, 33F, 23B and 38 were from PspA family 1, while NVTs 35B, 15C, 15B and 11A/11D isolates were from family 2. In contrast, genetically distinct PspAs were found in NVTs 6C and 15A. PspA family 3/clade 6 was detected in only NVT serotype 37 isolates assigned to ST447 and ST7970, showing the mucoid phenotype.
CONCLUSION: The present study revealed the predominance of PspA families 1 and 2 in NVTs, and the presence of family 3 in serotype 37.

Entities:  

Keywords:  Streptococcus pneumoniae; antimicrobial resistance; non-vaccine serotype; pneumococcal surface protein A (PspA); sequence type

Mesh:

Substances:

Year:  2018        PMID: 29927374     DOI: 10.1099/jmm.0.000775

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.

Authors:  Ana Rita Narciso; Federico Iovino; Sigrun Thorsdottir; Peter Mellroth; Mario Codemo; Christian Spoerry; Francesco Righetti; Sandra Muschiol; Staffan Normark; Priyanka Nannapaneni; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-01       Impact factor: 12.779

2.  Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader.

Authors:  Natalie Groves; Carmen L Sheppard; David Litt; Samuel Rose; Ana Silva; Nina Njoku; Sofia Rodrigues; Zahin Amin-Chowdhury; Nicholas Andrews; Shamez Ladhani; Norman K Fry
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

3.  Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan.

Authors:  Bin Chang; Yuki Kinjo; Masatomo Morita; Kosuke Tamura; Hiroshi Watanabe; Yoshinari Tanabe; Koji Kuronuma; Jiro Fujita; Kengo Oshima; Takaya Maruyama; Shuichi Abe; Kei Kasahara; Junichiro Nishi; Tetsuya Kubota; Makoto Ohnishi; Shigeru Suga; Kazunori Oishi
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

Review 4.  A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae.

Authors:  Jessica R Lane; Muralidhar Tata; David E Briles; Carlos J Orihuela
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.